Allogene Therapeutics, Inc. financial data

Symbol
ALLO on Nasdaq
Location
South San Francisco, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 12 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 867% % -19%
Debt-to-equity 37% % 36%
Return On Equity -57% % -3.2%
Return On Assets -42% % 4.2%
Operating Margin -1241814% % -260%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 243,777,920 shares 12%
Common Stock, Shares, Outstanding 229,413,523 shares 8.1%
Entity Public Float $184,000,000 USD -48%
Common Stock, Value, Issued $229,000 USD 8%
Weighted Average Number of Shares Outstanding, Basic 220,622,669 shares 13%
Weighted Average Number of Shares Outstanding, Diluted 220,622,669 shares 13%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $0 USD -100%
Research and Development Expense $150,152,000 USD -22%
General and Administrative Expense $56,781,000 USD -13%
Operating Income (Loss) $209,315,000 USD 23%
Nonoperating Income (Expense) $18,429,000 USD 15%
Net Income (Loss) Attributable to Parent $190,886,000 USD 26%
Earnings Per Share, Basic -0.87 USD/shares 34%
Earnings Per Share, Diluted -0.87 USD/shares 34%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $51,688,000 USD -31%
Cash, Cash Equivalents, and Short-term Investments $258,300,000 USD -31%
Assets, Current $257,749,000 USD -15%
Property, Plant and Equipment, Net $72,839,000 USD -15%
Operating Lease, Right-of-Use Asset $39,888,000 USD -12%
Other Assets, Noncurrent $3,615,000 USD 55%
Assets $415,905,000 USD -24%
Accounts Payable, Current $4,270,000 USD -21%
Employee-related Liabilities, Current $10,241,000 USD -16%
Contract with Customer, Liability, Current $86,000 USD 0%
Liabilities, Current $32,514,000 USD -8.5%
Operating Lease, Liability, Noncurrent $75,045,000 USD -9.9%
Other Liabilities, Noncurrent $15,804,000 USD 104%
Liabilities $123,363,000 USD -2.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax $269,000 USD
Retained Earnings (Accumulated Deficit) $2,010,709,000 USD -10%
Stockholders' Equity Attributable to Parent $292,542,000 USD -31%
Liabilities and Equity $415,905,000 USD -24%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $52,929,000 USD 5.3%
Net Cash Provided by (Used in) Financing Activities $13,990,000 USD 748%
Net Cash Provided by (Used in) Investing Activities $6,176,000 USD -72%
Common Stock, Shares Authorized 400,000,000 shares 0%
Common Stock, Shares, Issued 229,413,523 shares 8.1%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $32,763,000 USD -2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $61,980,000 USD -28%
Deferred Tax Assets, Valuation Allowance $501,766,000 USD 13%
Deferred Tax Assets, Gross $512,928,000 USD 13%
Operating Lease, Liability $83,253,000 USD -8.3%
Depreciation $3,555,000 USD 1.4%
Payments to Acquire Property, Plant, and Equipment $99,000 USD 1138%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $190,528,000 USD 26%
Lessee, Operating Lease, Liability, to be Paid $106,245,000 USD -11%
Property, Plant and Equipment, Gross $145,372,000 USD -2.2%
Operating Lease, Liability, Current $8,208,000 USD 9.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two $13,613,000 USD 3.4%
Lessee, Operating Lease, Liability, to be Paid, Year One $13,164,000 USD 1.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.0649 pure 3.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $22,992,000 USD -19%
Lessee, Operating Lease, Liability, to be Paid, Year Three $14,078,000 USD 3.4%
Deferred Tax Assets, Operating Loss Carryforwards $315,470,000 USD 29%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $24,220,000 USD 10%
Lessee, Operating Lease, Liability, to be Paid, Year Four $15,480,000 USD 10%
Operating Lease, Payments $3,100,000 USD 3.3%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $3,099,000 USD -13%
Share-based Payment Arrangement, Expense $37,641,000 USD -27%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%